Market | Anhui Liberty Showcased at China Veterinary Drug Conference and Exhibition 2026 On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidiary of Leadsynbio, joined the provincial delegationas a representative of outstanding animal health enterprises from Anhui, engaging with industry peers to explore new dynamics in the sector.

Market | Leadsynbio shines at CPHI China 2026 with a diversified biomanufacturing product portfolio From June 16 to 18, Leadsynbio made a strong impression atCPHI China 2026, showcasing a range of synthetic biology achievements and its internationally competitive product portfolio, while engaging with industry peers to explore future trends and partnership opportunities.

Leadsynbio has been honored with second prize of the Provincial Science and Technology Progress Award Recently, Leadsynbio has been honored withsecond prize of the Hunan Provincial Science and Technology Progress Award. The award-winning project’s achievements were selected as a landmark product in the 2026 Hunan Provincial Future IndustryInnovation and Development Excellent Typical Cases, gaining dual provincial authoritative recognition.

Leadsynbio has been recognized as a "Key Nurturing Enterprise in Biomanufacturing" in Suzhou On May 14th, Lesdsynbio was invited to attend the Suzhou Biomanufacturing Industry Development Conference and was awarded the title of "Key Nurturing Enterprise in Biomanufacturing" in Suzhou.